JP2023065401A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023065401A5 JP2023065401A5 JP2023016292A JP2023016292A JP2023065401A5 JP 2023065401 A5 JP2023065401 A5 JP 2023065401A5 JP 2023016292 A JP2023016292 A JP 2023016292A JP 2023016292 A JP2023016292 A JP 2023016292A JP 2023065401 A5 JP2023065401 A5 JP 2023065401A5
- Authority
- JP
- Japan
- Prior art keywords
- controlled release
- neuroprotective
- preparation
- core
- biodegradable polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410748P | 2016-10-20 | 2016-10-20 | |
| US62/410,748 | 2016-10-20 | ||
| PCT/US2017/057606 WO2018075901A1 (en) | 2016-10-20 | 2017-10-20 | Methods of delivering a neuroprotective polypeptide to the central nervous system |
| JP2019521018A JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Division JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023065401A JP2023065401A (ja) | 2023-05-12 |
| JP2023065401A5 true JP2023065401A5 (https=) | 2024-09-24 |
Family
ID=60382598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Active JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Active JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11273130B2 (https=) |
| EP (2) | EP3528836A1 (https=) |
| JP (2) | JP7626362B2 (https=) |
| KR (2) | KR102687778B1 (https=) |
| CN (1) | CN110191717A (https=) |
| AU (1) | AU2017345724B2 (https=) |
| BR (1) | BR112019008021A2 (https=) |
| CA (1) | CA3040906A1 (https=) |
| MX (1) | MX2019004476A (https=) |
| SG (1) | SG11201903462UA (https=) |
| WO (1) | WO2018075901A1 (https=) |
| ZA (1) | ZA201902486B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110191717A (zh) | 2016-10-20 | 2019-08-30 | 佩特通公司 | 向中枢神经系统递送神经保护性多肽的方法 |
| BR112022001595A2 (pt) * | 2019-07-29 | 2022-03-22 | Peptron Inc | Composição farmacêutica para tratamento ou inibição da progressão da discinesia induzida por levodopa |
| EP4005587B1 (en) * | 2019-07-29 | 2026-03-18 | Peptron, Inc. | Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof |
| JP2023526512A (ja) * | 2020-05-22 | 2023-06-21 | トラスティーズ オブ ボストン ユニバーシティ | 線維化疾患を処置するための方法および組成物 |
| CN112014193B (zh) * | 2020-07-24 | 2021-06-15 | 武汉大学中南医院 | 一种新的fj染色方法和装置 |
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| US12514908B2 (en) | 2021-07-05 | 2026-01-06 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| CN116392576A (zh) * | 2023-05-26 | 2023-07-07 | 南通大学 | 一种gip受体激动剂在制备治疗脊髓损伤修复靶点药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US5609885A (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device |
| US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ES2233768T3 (es) | 1996-02-02 | 2005-06-16 | Alza Corporation | Liberacion prolongada de un agente activo utilizando un sistema implantable. |
| US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6132420A (en) | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| US6261584B1 (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ZA981610B (en) | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| MY125849A (en) | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| CA2299425A1 (en) | 1997-08-08 | 1999-02-18 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds |
| ATE383867T1 (de) | 1997-11-14 | 2008-02-15 | Amylin Pharmaceuticals Inc | Neuartige exendin agonisten |
| ES2182379T3 (es) | 1997-12-22 | 2003-03-01 | Alza Corp | Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos. |
| JP4173635B2 (ja) | 1997-12-29 | 2008-10-29 | インターシア セラピューティクス，インコーポレイティド | 膜プラグ保持機構を有する浸透供給装置 |
| WO1999033449A1 (en) | 1997-12-30 | 1999-07-08 | Alza Corporation | Beneficial agent delivery system with membrane plug |
| JP4383674B2 (ja) | 1998-12-31 | 2009-12-16 | インターシア セラピューティクス，インコーポレイティド | 空間効率のよいピストンを有する浸透圧送達システム |
| CA2402637C (en) | 1999-12-21 | 2007-04-10 | Alza Corporation | Valve for osmotic devices |
| US7163688B2 (en) | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| EP1411968B1 (en) | 2001-07-31 | 2008-09-17 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Glp-1 exendin-4 peptide analogs and uses thereof |
| MXPA05000224A (es) | 2002-06-26 | 2005-06-03 | Alza Corp | Piston de volumen eficiente, minimamente deformable, para sistemas de suministro osmotico de farmacos. |
| US7014636B2 (en) | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| ATE387236T1 (de) | 2003-03-31 | 2008-03-15 | Alza Corp | Osmotische pumpe mit mitteln zum ableiten des innendrucks |
| US20080318837A1 (en) * | 2003-12-26 | 2008-12-25 | Nastech Pharmaceutical Company Inc. | Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide |
| US20050175701A1 (en) | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| US8168222B2 (en) * | 2004-09-07 | 2012-05-01 | Board Of Regents Of The University Of Nebraska | Amphiphilic polymer-protein conjugates and methods of use thereof |
| MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
| EP2049081B1 (en) | 2006-08-09 | 2012-11-14 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| KR100805208B1 (ko) * | 2007-03-27 | 2008-02-21 | 주식회사 펩트론 | 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법 |
| HRP20130259T1 (hr) | 2007-04-23 | 2013-04-30 | Intarcia Therapeutics, Inc. | Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe |
| SMT201700583T1 (it) | 2009-09-28 | 2018-01-11 | Intarcia Therapeutics Inc | Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario |
| US9259432B1 (en) * | 2011-01-31 | 2016-02-16 | Parminder J. S. Vig | Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases |
| US20140220134A1 (en) | 2011-06-24 | 2014-08-07 | Astrazeneca Pharamceuticals LP | Method for treating diabetes with extended release formulation of glp-1 receptor agonists |
| JP6226510B2 (ja) | 2012-01-27 | 2017-11-08 | キヤノン株式会社 | 画像処理システム、処理方法及びプログラム |
| ITMI20130325A1 (it) | 2013-03-05 | 2014-09-06 | Telecom Italia Spa | Metodo per misurare e monitorare il livello di accesso a dati personali generati da risorse di un dispositivo d'utente |
| JP2015192425A (ja) | 2014-03-28 | 2015-11-02 | 富士通株式会社 | デマンド収容変更順序決定方法、およびデマンド収容変更順序決定プログラム |
| US20170035856A1 (en) * | 2014-04-16 | 2017-02-09 | Shandong Luye Pharmaceutical Co., Ltd. | Exenatide-containing composition and preparation method therefor |
| CN110191717A (zh) | 2016-10-20 | 2019-08-30 | 佩特通公司 | 向中枢神经系统递送神经保护性多肽的方法 |
-
2017
- 2017-10-20 CN CN201780078697.6A patent/CN110191717A/zh active Pending
- 2017-10-20 EP EP17800650.8A patent/EP3528836A1/en not_active Withdrawn
- 2017-10-20 MX MX2019004476A patent/MX2019004476A/es unknown
- 2017-10-20 EP EP25181393.7A patent/EP4635569A3/en active Pending
- 2017-10-20 KR KR1020217022385A patent/KR102687778B1/ko active Active
- 2017-10-20 US US16/342,685 patent/US11273130B2/en active Active
- 2017-10-20 BR BR112019008021A patent/BR112019008021A2/pt unknown
- 2017-10-20 AU AU2017345724A patent/AU2017345724B2/en active Active
- 2017-10-20 WO PCT/US2017/057606 patent/WO2018075901A1/en not_active Ceased
- 2017-10-20 JP JP2019521018A patent/JP7626362B2/ja active Active
- 2017-10-20 KR KR1020197014421A patent/KR20190086460A/ko not_active Ceased
- 2017-10-20 SG SG11201903462UA patent/SG11201903462UA/en unknown
- 2017-10-20 CA CA3040906A patent/CA3040906A1/en active Pending
-
2019
- 2019-04-17 ZA ZA2019/02486A patent/ZA201902486B/en unknown
-
2021
- 2021-11-09 US US17/522,687 patent/US11771657B2/en active Active
-
2023
- 2023-02-06 JP JP2023016292A patent/JP2023065401A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023065401A5 (https=) | ||
| RU2408368C2 (ru) | Препараты соли бупропиона с модифицированным высвобождением | |
| US5716621A (en) | Nonocclusive drug delivery device and process for its manufacture | |
| JP4703470B2 (ja) | エチルセルローズ水性分散液で被覆した放出制御製剤 | |
| JP5410299B2 (ja) | 組換えゼラチンを含む制御放出組成物 | |
| CN101522146B (zh) | 具有高活性成分利用率和定量给药精确度的透皮治疗系统 | |
| JP2001508038A (ja) | 粘膜表面および身体組織に付与可能な薬学的ゲル調製物 | |
| KR930007440A (ko) | 미소립자 서방제 및 그의 제조방법 | |
| JP2010531343A (ja) | 生分解性パッチ | |
| DE60124294D1 (de) | Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe | |
| KR100334435B1 (ko) | 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법 | |
| KR101747411B1 (ko) | 신경전달물질을 조절하는 펩타이드의 신경세포 전달용 용해성 미세바늘 | |
| CA2359812A1 (en) | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures | |
| WO2004026262A3 (en) | Abuse-resistant pharmaceutical compositions | |
| JPWO2018075901A5 (https=) | ||
| JP2008512411A (ja) | 接着剤層を含む経皮治療システム、このシステムの支持層をシリコン処理する方法およびこの支持層の使用 | |
| KR101833821B1 (ko) | 패치 | |
| CN115475048A (zh) | 滥用和误用制止透皮系统 | |
| BR0206515A (pt) | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula, e uma formulação | |
| HU221594B (hu) | Tapasz illó, gyógyászatilag hatásos, bázisos anyagok bőrön keresztül történő bevitelére, valamint eljárás ennek előállítására | |
| JP2008507495A (ja) | 活性本体の経皮送達用デバイス | |
| RU2220714C2 (ru) | Единичная твердая дозированная форма рапамицина для орального применения (варианты), способ ее получения | |
| WO2001013898A3 (en) | Pharmaceutical formulations with different release times | |
| KR20140013436A (ko) | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 | |
| CN1469707A (zh) | 改进的疏水性药物的固体药物剂量制剂 |